Scrip is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

A Sign of the Times: Chi-Med’s MediPharma Steps Toward Independence

This article was originally published in PharmAsia News

Executive Summary

Accompanying the solid interim results announced by Hutchison China MediTech this week was an interesting indication of both the success of Chi-Med's Hutchison MediPharma R&D subsidiary and the evolution of the nascent biotech industry in China

You may also be interested in...



China’s Hutchison MediPharma Freezes Development Of Cancer Drug, Signs Development Deal With Janssen

BEIJING - Shanghai-headquartered Hutchison MediPharma has frozen development of a cancer drug after Phase II clinical trials conducted in China produced inconclusive data on the efficacy of the medicine, according to company executives

China’s Hutchison MediPharma Freezes Development Of Cancer Drug, Signs Development Deal With Janssen

BEIJING - Shanghai-headquartered Hutchison MediPharma has frozen development of a cancer drug after Phase II clinical trials conducted in China produced inconclusive data on the efficacy of the medicine, according to company executives

Chi-Med CEO Christian Hogg: An Interview With PharmAsia News (Part 2 of 2)

Chi-Med CEO Christian Hogg sat down recently with PharmAsia News to discuss how traditional Chinese medicine (TCM) serves as both the foundation for Chi-Med's success and as its platform for growth. Chi-Med is focused on researching, developing, manufacturing and selling pharmaceuticals, health supplements and other health care and personal care products derived from TCM and botanical ingredients.

Related Content

UsernamePublicRestriction

Register

LL1126271

Ask The Analyst

Please Note: Click here for more information on the Ask the Analyst service.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel